Markets.com Logo

ABUS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.571$
  • Previous Close
    3.5561$
  • 52 Week Change
    2.02$
  • Day Range
    0.01$
  • 52 Week High/Low
    2.705$ - 4.725$
  • Dividend Per Share
    --
  • Market cap
    686 M$
  • EPS
    0.01
  • Beta
    0.861
  • Volume
    --

About

ABUS.US is the stock ticker symbol for Arbutus Biopharma Corporation, a Canadian biopharmaceutical company focused on developing novel therapeutics targeting chronic hepatitis B virus (HBV) infection. The ".US" suffix indicates that the stock is traded on a United States stock exchange, specifically the Nasdaq Global Select Market. Arbutus Biopharma's research and development efforts are aimed at creating a functional cure for HBV, which would involve eliminating the virus from the body and preventing its recurrence. The company is pursuing multiple approaches, including RNA interference (RNAi), capsid inhibitors, and PD-L1 inhibitors, to achieve this goal. Their progress is closely watched by investors and the medical community alike, as a successful HBV cure would have a significant impact on public health.

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Howard Marks on Market Cycles, Value Investing Logic, and Current Economic Shifts

Sophia Claire|--
EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

Ghko B|--

Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook

Sophia Claire|--
Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Ghko B|--

Factors

Company Performance: Positive clinical trial results or FDA approvals typically increase the stock price.

Market Sentiment: Overall investor optimism or pessimism impacts all stocks, including ABUS.US.

Industry Trends: Developments in the cell and gene therapy sector influence ABUS.US valuation.

Regulatory Changes: New regulations affecting drug development can impact ABUS.US stock price.

Competition: Advances by competitors in similar therapies can negatively affect ABUS.US.

Financial Health: ABUS's cash position and burn rate are key factors influencing investors.

Economic Conditions: Macroeconomic factors like inflation and interest rates impact stock valuations.

Partnerships: Collaborations with larger pharmaceutical companies can boost ABUS.US stock price.

News & Events: Announcements regarding earnings, partnerships, or clinical data directly affect ABUS.US.

People Also Watch

Latest news

Fed Leadership Uncertainty: Powell's Potential Continuation and Political Hurdles

Ava Grace|--

Gerrymandering Backfires: Republicans Fear Election Losses as Districts Are Redrawn

Emma Rose|--

Fed Nomination Stalemate: Republican Opposition Halts Warsh's Senate Confirmation

Sophia Claire|--

Latest Education Articles

What Are Non-Farm Payrolls? A Simple Guide for Traders

What Are Non-Farm Payrolls? A Simple Guide for Traders

Julian Parker|--
What Is Spread Betting and How Does It Work? A Clear Guide for Traders

What Is Spread Betting and How Does It Work? A Clear Guide for Traders

Julian Parker|--
What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

Julian Parker|--
Recommended Topics